Allergy & Immunology Doctors in Anchorage, AK Accepting Medicare

6 Allergy & Immunology doctors found. Showing 1 - 6

David A Hemry, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3841 Piper Street, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228    Fax: 907-562-6868

Dr. Melinda Mcneal Rathkopf, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper Street, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228    Fax: 907-562-6868

Dr. Stephen Neal Marks, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St Ste T4-054, Anchorage, AK 99508 Phone: 907-562-6228    Fax: 907-562-6868

Jeffrey G Demain, M.D Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228    Fax: 907-562-6868

Mrs. Laura M Moore, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper Street, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228    Fax: 907-562-6868

Dr. Eric Albert Meier, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228    Fax: 907-562-6868

News Archive

Data analysis of Delcath Systems' Phase III trial of melphalan to be commenced

Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for metastatic cancers to the liver, announced today that sufficient events have been reached to allow data analysis to begin on its Phase III trial. The trial uses the drug melphalan to treat patients with metastatic melanoma in the liver.

Concentric Medical receives expanded indication for DAC family of neurovascular catheters

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced an important expanded indication for the full line of DAC™ Neurovascular Catheters. CE Mark was granted allowing the DAC family of distal access catheters to be used for the removal/aspiration of fresh, soft emboli and thrombi from vessels in the arterial system, including the neurovasculature.

UNEP should work to bring about safe alternatives to DDT for malaria vector control

Some countries in Africa "still rely on dichlorodiphenyltrichloroethane (DDT) for malaria vector control," therefore "[i]t is ... problematic that the U.N. Environment Programme (UNEP), without the consent of member states, and violating its own treaties, exerts relentless pressure to ban DDT globally," Richard Tren, director of Africa Fighting Malaria, and Richard Nchabi Kamwi, Nambia's minister of health and social services, write in a BMJ opinion piece.

Griffith research unlocks more about cancer

A research collaboration between Griffith and the Malaghan Institute in Wellington, New Zealand has made the discovery that mitochondria are capable of passing through the healthy membrane of a host cell into defective tumour cells, possibly kicking off the rapid proliferation of tumour cells which is the hallmark of cancer.

New strategy involving three-pronged approach may keep lung cancer aside

Lung cancer is the leading cause of cancer death worldwide, responsible for some 1.59 million deaths a year. That figure is due, in part, to the fact that lung cancer often returns after what seems at first to be successful treatment. However, the recurring cancer is often resistant to the chemotherapy and other drugs that originally drove it into remission.

Read more Medical News

› Verified 9 days ago